Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Nanospun Technologies Ltd. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These active matters are distributed across 2 distinct examiners, which suggests that the company's current prosecution efforts are not concentrated under 1 individual. This distribution can impact the consistency of feedback received from the patent office.
The prosecution activity is further divided among 2 distinct art units. This indicates that the company's patent applications are being evaluated by different specialized groups within the Biotechnology & Pharmaceuticals sector. Navigating 2 distinct art units requires a strategy that accounts for the specific examination trends and requirements of each group.
CHI, AMANDA LYNN is identified as the busiest examiner for the portfolio, currently overseeing 1 pending office action. While this examiner holds the highest number of pending actions for the company, the total volume of 2 pending office actions remains low. Practitioners should monitor the progress of the action under CHI, AMANDA LYNN to determine if her specific examination style influences the broader portfolio strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHI, AMANDA LYNN | 1 | — | — |
| CHAU, LINDA N | 1 | 44.7% | +15.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15558238 | MULTI-LAYERED MICROFIBERS AND USE THEREOF | CHAU, LINDA N | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15558238 | MULTI-LAYERED MICROFIBERS AND USE THEREOF | CHAU, LINDA N | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| 1785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18728203 | ARTIFICIAL SKIN COMPRISING FIBROUS MAT | CHI, AMANDA LYNN | 1614 | §103§112DP | Non-Final OA | — | Pending | Jul 11, 2024 |
| 15558238 | MULTI-LAYERED MICROFIBERS AND USE THEREOF | CHAU, LINDA N | 1785 | §103§112 | Non-Final OA | — | Pending | Sep 14, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNanospun Technologies Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Amanda Lynn Chi has the most, with 1 of Nanospun Technologies Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
